The Economic Evolution of Brooklyn Park, Minnesota

To comprehend why specific advanced industries clustered in Brooklyn Park, Minnesota, it is necessary to trace the municipality’s geographical, demographic, and economic evolution. Situated on the west bank of the Mississippi River within northern Hennepin County, Brooklyn Park is currently the sixth-largest city in Minnesota, boasting a population exceeding 86,000 residents. The region’s industrial trajectory is deeply intertwined with its historical agricultural dominance, subsequent infrastructure development, and proactive municipal economic policies.

The area was initially settled in 1853 by families migrating from Adrian, Michigan, and was organized as Brooklyn Township in 1858. Early economic activity centered around the Mississippi River, featuring sawmills and a boom house for sorting logs, alongside an ice harvesting facility. However, the region’s defining characteristic was its easily tilled, loamy, and sandy soil, which provided excellent drainage. While early farmers focused on wheat, the proximity to the rapidly expanding metropolis of Minneapolis prompted a shift toward market gardening and root vegetables, particularly potato farming. By the early twentieth century, the region was a national agricultural powerhouse; more carloads of potatoes were shipped from the adjacent Osseo rail depot than nearly anywhere else in the United States. Prominent homesteads, such as the August Tessman farm (established in 1883) and the Eidem Farm (purchased by John and Lectie Eidem in 1894), served as the economic engines of the township.

The transition from a rural agricultural settlement to a modern industrial hub began following World War II. As the Minneapolis metropolitan area expanded, land values in Brooklyn Park increased to a point where industrial and residential development became more lucrative than agriculture. The city formally incorporated in 1969, and local governance shifted toward attracting commercial investment. A critical catalyst for this transition was the development of major transportation arteries, specifically Interstate 94, U.S. Highway 169, and State Highway 610. These corridors provided the contiguous, undeveloped acreage necessary for large-scale manufacturing facilities that the densely packed inner-ring suburbs could no longer accommodate.

To manage this growth, the Brooklyn Park City Council established the Economic Development Authority (EDA) in 1988, which later absorbed the Housing and Redevelopment Authority in 1993. The EDA, operating in tandem with the Brooklyn Park Development Corporation (BPDC), actively courted advanced manufacturing, life sciences, and technology firms by leveraging state-level financial resources, including the Minnesota Investment Fund (MIF) and the Job Creation Fund (JCF).

Presently, the city is executing its most ambitious economic initiative: the Northwest Growth Area Plan. This framework guides the development of over 700 acres of largely undeveloped land in the city’s northwest corner, primarily focused on establishing a BioTech Innovation District. Anchored by existing medical technology titans, this district is designed to attract life sciences, medical device manufacturing, and precision engineering firms, supported by infrastructure enhancements such as the upcoming METRO Blue Line light rail extension. This deliberate transition from agrarian root-crop farming to precision biotechnology and automated manufacturing forms the foundation for the five industry case studies analyzed below.

Brooklyn Park Industry Case Studies: Application of the R&D Tax Credit

The following case studies illustrate how distinct industrial sectors developed within the borders of Brooklyn Park and detail the methodologies by which their technical operations qualify for the United States federal and Minnesota state Research and Development tax credits.

Case Study: Medical Devices and Biotechnology Biomanufacturing

The state of Minnesota is globally recognized as “Medical Alley,” a premier health technology cluster whose origins trace back to Earl Bakken’s commercialization of the battery-powered wearable cardiac pacemaker at Medtronic in the late 1950s. As the regional medical device and pharmaceutical industries scaled globally, legacy corporations required massive manufacturing footprints featuring ISO-certified cleanrooms and highly regulated production environments. Brooklyn Park emerged as a primary destination due to the availability of large land parcels along the Highway 610 corridor, robust utility infrastructure, and proximity to the University of Minnesota’s research talent pool.

This supportive ecosystem attracted major global investments. In 2016, Takeda Pharmaceutical Company Limited acquired a state-of-the-art biologics manufacturing facility in Brooklyn Park from Baxalta US Inc. Located at 9450 Winnetka Avenue North, the facility was strategically acquired to serve as a global center of excellence for manufacturing Entyvio (vedolizumab), a complex biologic therapy utilized in the treatment of moderately to severely active ulcerative colitis and Crohn’s disease. Takeda further expanded this campus following a forty-five million dollar investment, culminating in the U.S. Food and Drug Administration (FDA) approving the facility for commercial drug substance production in 2020. Similarly, Olympus Corporation established a major research, development, and manufacturing facility in Brooklyn Park dedicated to minimally invasive surgical products and gastrointestinal endoscopy devices. Biomerics, an advanced catheter contract manufacturer, also constructed a fifty-two thousand square foot facility near the intersection of U.S. Route 169 and State Highway 610, integrating polymer engineering offices with large-scale cleanroom manufacturing operations.

Biomanufacturing and medical device engineering companies operating in Brooklyn Park engage in highly complex scaling operations that inherently meet the rigorous requirements of the United States federal and Minnesota state R&D tax credits. Scaling a biologic drug from a laboratory environment to commercial-scale bioreactors involves immense technical uncertainty regarding cellular viability, nutrient feed rates, agitation shear stress, and downstream purification yields. Process engineers and biochemists at facilities like Takeda’s must conduct systematic trial-and-error experimental runs to determine the optimal bioreactor parameters that maintain product efficacy without degrading the complex protein structures.

This research is strictly technological in nature, relying upon the fundamental principles of biochemistry, molecular biology, and fluid dynamics. The wages paid to the process engineers, quality control scientists, and microbiologists designing and executing these scale-up protocols constitute the primary Qualified Research Expenses (QREs). Additionally, the expensive raw chemical substrates, specialized filters, and disposable bioreactor bags consumed during failed or iterative experimental runs qualify as supply QREs. Because these physical bioreactors and cleanrooms are located entirely within Brooklyn Park, the activities fully qualify for the Minnesota state R&D credit, which strictly mandates geographic nexus.

Case Study: Advanced Manufacturing and Precision Machining

As the medical device, aerospace, and defense sectors expanded throughout the Twin Cities metropolitan area, a highly localized supply chain of precision machining and contract manufacturing was necessitated. Original equipment manufacturers (OEMs) sought suppliers located in immediate proximity to minimize logistical costs and facilitate rapid prototyping iterations. Brooklyn Park’s industrial zoning provided the necessary infrastructure, including heavy-duty electrical grids and reinforced foundation capabilities required to operate massive computer numerical control (CNC) and stamping machinery.

Enterprises such as EDM Intelligent Solutions (EDMIS) established operations in Brooklyn Park to provide ultra-precision electrical discharge machining (EDM) services. Utilizing advanced wire EDM, sinker EDM, and laser ablation technologies, the company achieves geometric tolerances as tight as one single micron. Their production portfolio includes mechanical flight surface actuators for the aerospace industry, interconnect assemblies for communications, and surgical implants for the medical sector. Additionally, localized firms such as Rotation Engineering have heavily expanded their footprint. Supported by the Brooklyn Park EDA and leveraging six hundred and forty thousand dollars from the Minnesota Investment Fund alongside two hundred and ninety-five thousand dollars from the Job Creation Fund, Rotation Engineering expanded its facility to sixty-four thousand square feet to house advanced automation systems and a new four hundred ton punch press.

For precision manufacturers and job shops, R&D tax credit eligibility is typically embedded within the engineering design, custom tooling, and initial prototyping phases of fabrication. When a company like EDMIS receives a contract to machine a novel turbine component from an experimental aerospace alloy, standard machining parameters are entirely insufficient due to unknown material hardness, heat dissipation characteristics, or geometric complexities. The engineering team must design a “pilot model” of the machining process itself. The iterative engineering hours required to design custom holding fixtures, formulate the exact electrical pulse parameters for the EDM wire, and test various coolant flow rates to prevent micro-fracturing directly qualify as a process of experimentation intended to resolve technical uncertainty.

A critical compliance factor for contract manufacturers in this space revolves around the legal nature of their client agreements. If a Brooklyn Park machine shop operates strictly as a “build-to-print” facility—where the client provides finalized blueprints and pays an hourly rate regardless of the outcome—the research is considered “funded” by the client and is statutorily ineligible for the credit. Conversely, if the manufacturer bids on a fixed-price contract to achieve a highly specific micron tolerance, thereby assuming the financial risk of scrapped metal and unpaid iterative engineering time, the activity qualifies. The consumable tooling bits used in failed iterations, the scrap metal, and the programming wages incurred within the Brooklyn Park machine shop are strictly eligible for both the federal credit and the Minnesota state credit.

Case Study: Food Science, Agricultural Technology, and Food Processing

The transition of Brooklyn Park from a sprawling agricultural landscape to a densely populated industrial suburb did not erase the region’s agrarian heritage; rather, the industry modernized and evolved into food science and agricultural technology (AgTech). The city’s historical dominance in potato farming—exemplified by the massive operations of the Tessman and Eidem families—created a deep regional understanding of crop management and food supply logistics. Eldon Tessman, a descendant of the original 1883 homesteaders, famously dedicated portions of his Brooklyn Park potato farm to researchers from the University of Minnesota to test disease-resistant potato strains, directly bridging the gap between traditional farming and modern scientific experimentation.

Furthermore, the city’s geographical proximity to the global headquarters of major food conglomerates, such as General Mills and Cargill, created a fertile economic environment for specialized food science and processing firms. Modern AgTech and food manufacturing enterprises in Brooklyn Park focus on sustainable packaging, crop resiliency, and automated food processing to meet evolving consumer demands and regulatory standards.

Activities within food science and agricultural processing are frequently overlooked for R&D tax credits, yet they easily satisfy the statutory requirements when systematic, science-based processes are applied to resolve organic uncertainties. For example, a food processing facility in Brooklyn Park attempting to transition an established product line to utilize non-GMO, organic, or gluten-free alternative ingredients faces immense technical uncertainty regarding the product’s resulting shelf life, moisture retention, taste profile, and behavior during mechanical extrusion.

Developing these new recipes requires a rigorous process of experimentation. Food scientists must bake varying ratios of alternative flours, conduct blind organoleptic (taste and texture) testing, evaluate microbial growth over time to ensure food safety, and adjust the thermodynamics of the commercial ovens to prevent product degradation. Because these activities rely heavily on organic chemistry, microbiology, and thermodynamics, they are definitively technological in nature.

Moreover, AgTech companies operating within the city’s Northwest Growth Area developing automated indoor hydroponic systems, testing new soil moisture sensors, or writing algorithms to optimize drought-resistant seed irrigation are conducting premier qualified research. The wages paid to the agronomists, software engineers, and food scientists executing these experiments are fully eligible for both the federal and state tax credits.

Case Study: Packaging Technology and Permeation Testing

The mid-twentieth-century shift in consumer goods packaging from heavy, rigid glass and metal containers to lightweight, polymer-based flexible packaging created a profound technical crisis for the food and pharmaceutical industries. Unlike glass or metal, polymer films are microscopically porous, allowing the permeation of ambient gases such as oxygen and water vapor, which rapidly degrades the enclosed products, leading to spoilage and loss of efficacy.

AMETEK MOCON (originally incorporated as Modern Controls) was founded in Brooklyn Park in 1966 by inventor Les Demorest to solve this exact technical challenge. Demorest invented the Infrared Detector (IRD), the world’s first instrument capable of automating and accurately measuring water vapor permeation through coated papers and packaging materials. Brooklyn Park provided an ideal incubator for AMETEK MOCON due to the immense concentration of food packagers in the Twin Cities area that desperately needed to test the shelf life of dry goods, cereals, and salty snacks as they transitioned to polypropylene and polyethylene packaging in the 1980s. Today, AMETEK MOCON operates a state-of-the-art manufacturing and laboratory facility on Mendelssohn Avenue North in Brooklyn Park, manufacturing the OX-TRAN and AQUATRAN analyzers that serve as the global ASTM standard for permeation testing.

The continuous engineering and development of highly sensitive analytical testing instrumentation perfectly aligns with the legislative intent of the research and development tax credit. As global packaging films evolve into highly complex, multi-layer high-barrier extrusions, the volume of gas permeating the barrier drops precipitously into the parts-per-billion (ppb) range. AMETEK MOCON’s engineering teams face severe technical uncertainty in designing sensors capable of isolating, capturing, and detecting such infinitesimal gas volumes without environmental interference or false positives.

Developing the next generation of analyzers to improve the speed, accuracy, and reliability of oxygen transmission rate (OTR) testing constitutes a qualified permitted purpose, as it aims to improve the performance and capability of a business component. To successfully claim the credit, the company must maintain contemporaneous documentation—such as CAD schematic iterations of the sensor housings, data logs of calibration failures during the prototype testing phase, and iterative algorithmic code adjustments for the user interface—to definitively prove that the majority of the research activities were experimental rather than routine. The physical metals, circuits, and calibration gases used to build and test these prototypes are eligible supply QREs under federal and state law.

Case Study: Industrial Automation and Robotics Integration

The extraordinary density of medical device manufacturing and high-tolerance precision machining in Brooklyn Park generated a secondary, highly specialized demand for industrial automation. Facilities requiring high-throughput, sterile, and hyper-accurate assembly lines could no longer rely on manual human labor due to the microscopic tolerances and cleanroom restrictions of modern medical devices. Consequently, systems integrators and specialized automation engineering firms clustered in the region to serve these localized OEMs.

Companies such as HAHN Automation Group US, Inc. established massive operational footprints in the city. Founded originally in 1993 as Invotec by two visionary manufacturing engineers, the company merged with the HAHN Group in 2017 and currently operates a thirty-two thousand two hundred and twenty-two square foot facility in Brooklyn Park. They specialize in developing bespoke automated manufacturing systems for the Bio-MEMS, cardiovascular device, and drug delivery system sectors. Similarly, value-added distributors and robotic systems integrators like Automation, Inc. provide local manufacturers with the necessary machine vision, pneumatic, and motion control technologies required to build these complex lines.

The integration of advanced robotic systems is fraught with mechanical, electrical, and software-driven technical uncertainties that qualify for massive federal and Minnesota R&D tax credits. When an automation firm designs a custom robotic cell to assemble a novel cardiovascular catheter, the off-the-shelf robotic arm must be extensively programmed with custom kinematic algorithms to integrate flawlessly with specialized machine vision cameras that inspect the microscopic parts. The technical uncertainty lies in achieving the customer’s required rapid cycle times, ensuring absolute collision avoidance within a highly confined physical footprint, and calibrating the vision system’s lighting and software to accurately reject micro-defects.

A critical nuance in this sector involves the development of software. If the automation firm develops software embedded directly into the machine sold to the customer, it is evaluated under the standard four-part test. However, if a local Brooklyn Park manufacturer develops proprietary software solely to run its own internal automated warehouse or enterprise resource planning (ERP) system, it must pass an elevated “High Threshold of Innovation” test. This requires proving that the internal-use software results in significant cost reduction or speed improvement and entails substantial technical risk that cannot be resolved using commercially available solutions. The wages of the robotics programmers, electrical engineers, and mechanical designers stationed in the Brooklyn Park facilities represent the primary QREs, alongside the raw materials consumed in building the physical testing jigs.

Detailed Analysis: The United States Federal R&D Tax Credit Framework

The foundation of innovation incentivization in the United States is the federal Credit for Increasing Research Activities, codified under Title 26 of the United States Code (U.S.C.), specifically Internal Revenue Code (IRC) Section 41. Originally enacted in 1981, the credit is explicitly designed to stimulate domestic economic growth by reducing the after-tax cost of research and development for businesses operating within the United States. The credit operates on an incremental basis; it does not merely reward total research expenditures, but rather specifically targets and rewards the increase in a taxpayer’s research efforts over a historically established baseline, known as the base amount.

The Statutory Definition of Qualified Research: The Four-Part Test

The Internal Revenue Service (IRS) strictly regulates what constitutes eligible research. To classify an activity as “qualified research,” the taxpayer must satisfy a rigorous four-part test as outlined in IRC Section 41(d). This test is applied at the level of the “business component,” defined as any product, process, computer software, technique, formula, or invention to be held for sale, lease, or license, or used by the taxpayer in their trade or business. Failure to meet any single criterion of the four-part test completely disqualifies the activity.

Qualified Research Expenses (QREs)

If a project satisfies the four-part test, the taxpayer must then isolate the specific costs directly associated with the qualified activities. Under IRC Section 41(b), Qualified Research Expenses (QREs) are strictly defined and limited to specific categories when conducted in-house, alongside rigid provisions for contract research:

• Wages for Qualified Services: This represents the largest portion of most R&D claims. It includes amounts paid or incurred to an employee for qualified services performed. This is not limited solely to the scientists executing the experiments; it legally encompasses individuals engaging in the direct supervision of the research (e.g., a Director of Engineering reviewing testing data) and the direct support of the research (e.g., a machinist fabricating a prototype part, or a lab technician cleaning testing beakers).
• Supplies Used in Conduct of Research: This encompasses amounts paid or incurred for tangible, non-depreciable property used in the direct conduct of qualified research. This includes raw materials consumed during prototype fabrication, chemicals used in testing, and specialized gases. It explicitly excludes land, improvements to land, and capital equipment (depreciable property).
• Computer Rental and Cloud Computing: Under regulations prescribed by the Secretary, any amount paid or incurred to another person for the right to use computers in the conduct of qualified research is eligible. In modern applications, this often includes cloud computing costs (such as AWS or Microsoft Azure) specifically utilized to host development environments, run massive computational simulations, or train artificial intelligence models.
• Contract Research Expenses: Recognizing that companies often outsource specialized testing, the statute allows taxpayers to claim a percentage of amounts paid to third parties for qualified research conducted on their behalf. Generally, this is limited to 65% of the total contract amount. However, this increases to 75% for amounts paid to qualified research consortiums (tax-exempt organizations operated primarily to conduct scientific research).

Federal Case Law Directives and IRS Administration

The application and interpretation of IRC Section 41 are continuously shaped by judicial precedent resulting from disputes between taxpayers and the IRS Large Business and International (LB&I) division. Recent Tax Court rulings have signaled a paradigm shift toward stricter enforcement of contemporaneous documentation and precise adherence to statutory definitions.

The landmark case of Little Sandy Coal Co., Inc. v. Commissioner (2021) established a highly stringent interpretation of the “substantially all” requirement within the process of experimentation test. The taxpayer sought credits for designing a new class of maritime vessel. The Tax Court denied significant portions of the claim because the company failed to provide quantitative, contemporaneous evidence proving that at least 80% of the total research activities were dedicated to a structured process of evaluating design alternatives. The court ruled that informal, undocumented trial-and-error operations are fundamentally insufficient. This ruling dictates that businesses must maintain rigorous, real-time documentation, including design iterations, test results, and engineering logs, to survive IRS scrutiny.

In Phoenix Design Group, Inc. v. Commissioner (2024), the Tax Court highlighted the absolute necessity of identifying specific technical uncertainties prior to commencing the research. The taxpayer, an engineering firm designing mechanical, electrical, and plumbing (MEPF) systems, argued that general uncertainty existed at the outset of their projects. The court denied the credits, stating that the IRS now expects clear documentation of specific technological uncertainties related to the core capability or design, rather than generalized statements regarding routine engineering challenges.

The concept of “funded research” under Section 41(d)(4)(H) was severely tested in Betz v. Commissioner (2023). The case involved Catalytic Products International (CPI), an S-corporation that designed custom air pollution control systems for clients. The Tax Court disallowed the claimed R&D credits, finding that for numerous projects, CPI did not retain substantial rights to the research results under the terms of their client contracts. Furthermore, if a client’s payment to the taxpayer is not explicitly contingent on the success of the taxpayer’s research activities (i.e., the taxpayer bears no financial risk of failure), the research is legally classified as “funded” by the client, rendering the contractor’s activities completely ineligible.

Conversely, the court provided favorable clarity for manufacturers in Intermountain Electronics, Inc. v. Commissioner (2024). The court evaluated whether production expenses incurred while developing a “pilot model” could qualify for the credit. Intermountain Electronics manufactured custom, first-of-their-kind electrical switchgears. The court confirmed that costs associated with building the physical pilot model could qualify under Section 174 if the fabrication of the model was inherently necessary to evaluate alternatives and resolve the technical uncertainties, even if that pilot model was eventually sold to the end customer.

Legislative Paradigm Shift: The 2025 One Big Beautiful Bill Act (OBBBA)

The regulatory landscape surrounding the financial treatment of R&D expenditures experienced a monumental shift with the passage of the One Big Beautiful Bill Act (OBBBA) in July 2025.

To understand the magnitude of this legislation, one must review the preceding framework. Under the 2017 Tax Cuts and Jobs Act (TCJA), businesses were subjected to a delayed funding mechanism that radically altered IRC Section 174. Starting in the 2022 tax year, companies could no longer immediately expense their domestic R&D costs; instead, they were forced to capitalize and amortize domestic R&D expenses over a five-year period (and foreign R&D over an aggressive fifteen-year period). This created severe cash flow crises for innovative manufacturing and software firms, as companies running net operational losses were suddenly faced with unexpected taxable income on paper due to the inability to deduct millions of dollars in current-year research expenditures.

The 2025 OBBBA entirely reversed this restrictive mandate for domestic operations. Effective for the 2025 tax year and beyond, U.S. businesses are once again permitted to fully and immediately deduct domestic R&D expenses in the year they are incurred. (Foreign R&D expenses must still be amortized over fifteen years, maintaining the incentive to onshore research operations).

This restoration of immediate expensing, coupled with the generous transition rules allowing the rapid deduction of pent-up unamortized costs from previous years, substantially enhances the financial viability of massive R&D investments, providing immediate liquidity to capital-intensive operations like those clustering in Brooklyn Park.

Detailed Analysis: The Minnesota State R&D Tax Credit Framework

While the federal credit provides the overarching structure, the state of Minnesota operates its own highly specific incentive program designed to foster an environment of industrial and technological innovation within its borders. The Minnesota Credit for Increasing Research Activities, codified under Minnesota Statutes Section 290.068, was established by the state legislature in 1981 and is fundamentally patterned after IRC Section 41. However, it features distinct regional requirements, strict geographic limitations, and unique computational mechanisms.

Structural Mechanisms and Base Amount Variations

The Minnesota R&D credit is calculated utilizing a specialized tiered rate structure to reward varying scales of investment. For taxable years beginning after December 31, 2016, a corporate entity, partners in a partnership, or shareholders in an S-corporation are allowed a credit equal to:

• 10% of the first $2,000,000 of excess qualified research expenses over the base amount.
• 4% of all excess qualified research expenses above that $2,000,000 threshold.

To claim the credit, the activities must satisfy the exact same four-part test as the federal government. However, Minnesota introduces critical deviations in the calculation of the “base amount” and the qualification of expenses:

• Strict Geographic Nexus: This is the most critical distinction. All QREs claimed for the Minnesota R&D credit must be physically conducted within the geographical boundaries of the state of Minnesota. If a Brooklyn Park manufacturer subcontracts research to an engineering firm in Wisconsin, those expenses are entirely ineligible for the state credit, regardless of their federal eligibility.
• Apportionment of Gross Receipts: The base amount formula relies heavily on historical gross receipts. For tax years occurring after May 30, 2017, the average annual gross receipts utilized in the base amount calculation must be determined using Minnesota sales or receipts apportioned under section 290.191, rather than the company’s total federal aggregate gross receipts. Interestingly, taxpayers who incur significant QREs in Minnesota but have zero gross receipts can still legally claim the credit.
• Exclusion of Alternative Simplified Credit (ASC): The federal framework allows taxpayers lacking historical data to use the Alternative Simplified Method (ASC) to calculate their base amount. Minnesota explicitly does not allow the federal ASC method, forcing all taxpayers to utilize the regular fixed-base percentage methodology.
• Innovation Grant Disallowance: If a taxpayer receives an Innovation Grant from the Minnesota Department of Employment and Economic Development (DEED), any specific expenditures funded by that grant are statutorily disqualified from being claimed as eligible QREs for the Minnesota R&D credit, preventing “double-dipping” of state funds.

Judicial Precedent in Minnesota: IBM v. Commissioner

The complexities of the Minnesota base amount calculation were heavily litigated in the Minnesota Supreme Court case International Business Machines Corporation (IBM) v. Commissioner of Revenue (2019). The case resolved two massive computational disputes between the Department of Revenue and corporate taxpayers.

First, the court ruled that the Minnesota Legislature’s incorporation of the federal tax code’s definition of “base amount” implicitly included the federal “minimum base amount” limitation. This limitation dictates that a taxpayer’s base amount can never be less than 50% of their current year QREs, effectively capping the maximum allowable credit calculation. Second, concerning the specific tax year in dispute (2011), the court ruled that the term “aggregate gross receipts” in the denominator of the fixed-base percentage referred to total federal aggregate gross receipts, not just Minnesota receipts. (It is imperative to note that the Minnesota Legislature subsequently amended Minn. Stat. § 290.068 in 2017 to explicitly mandate the use of Minnesota-only sales/receipts moving forward, functionally overriding the impact of the court’s decision for current tax years).

Transformational 2025 Updates: The Paradigm of Refundability Under House File 9

Historically, one of the primary criticisms of the Minnesota R&D credit was its nonrefundable nature. The credit could only be utilized to reduce current corporate franchise tax or individual income tax liabilities. For start-up enterprises, biotechnology firms in lengthy clinical trial phases, and heavy manufacturers experiencing cyclical net operating losses, this limitation made the credit functionally useless in the short term, as they lacked the tax liability to offset. Unused credits were simply relegated to a 15-year carryforward.

This landscape was fundamentally revolutionized on June 14, 2025, when Minnesota Governor Tim Walz signed House File 9 (H.F. 9) into law. This legislation modernized the statute by introducing partial refundability for the first time in the program’s history, aligning Minnesota with other highly competitive, innovation-driven states.

Under the new paradigm, taxpayers may elect to treat a portion of their unused current-year research credit as immediately refundable cash, rather than carrying it forward. The refundability calculation is highly structured and phases in over several years:

To access this newly generated liquidity, stringent administrative procedures must be followed. The taxpayer must make an explicit election to claim the refundable portion on a timely filed original tax return, including approved extensions. Crucially, once this election is chosen, it is entirely irrevocable for that specific tax year.

For pass-through entities (such as the numerous S-corporations and LLCs operating in Brooklyn Park’s industrial sectors), the entity itself calculates the credit on Schedule RD, but the credit is passed through to the individual shareholders or partners via Schedule KS or KPI. Under the new H.F. 9 rules, the election to take the refund is made at the individual partner or shareholder level, allowing for customized tax planning based on individual liability profiles. Any portion of the credit that is not elected for refund, or the remainder of the credit that exceeds the allowable refundability percentage, continues to carry forward for up to 15 years.

Furthermore, the legislation preserves complex allocation rules for large corporate entities operating as a unitary business group. The Minnesota R&D credit can be allocated among combined group members, but the member that actually earned the credit must use it to offset their own current year tax liability first, before allocating the excess or calculating the refundable portion.

Final Thoughts

The industrial tapestry of Brooklyn Park, Minnesota—ranging from its deep historical legacy in agricultural science and market farming to its current, highly engineered trajectory as a premier BioTech and advanced manufacturing nexus—presents profound opportunities for capital optimization. By successfully navigating the complexities of the United States federal and Minnesota state Research and Development tax credits, local enterprises can significantly subsidize the cost of their technological innovation.

The convergence of recent federal and state legislative actions has created an unprecedented fiscal environment for these operations. The federal 2025 One Big Beautiful Bill Act (OBBBA), which entirely restores the immediate expensing of domestic R&D under Section 174, provides immediate cash flow relief previously stifled by mandatory amortization. Concurrently, Minnesota’s enactment of House File 9 introduces highly lucrative refundability rates—19.2% for the 2025 tax year and 25% for 2026—transforming the state-level credit into a powerful tool for startups and pre-revenue biotech firms.

Whether a Brooklyn Park enterprise is scaling complex biologics in commercial bioreactors, engineering single-micron tolerance aerospace components, formulating next-generation sustainable food products, developing parts-per-billion gas permeation sensors, or coding intricate machine vision algorithms for robotic assembly lines, they are uniquely positioned to leverage these statutory incentives. However, the recent judicial precedents established in cases like Little Sandy Coal and Phoenix Design Group dictate that strict adherence to the four-part test, the maintenance of meticulous contemporaneous documentation, and a nuanced understanding of state apportionment rules remain the absolute critical imperatives for successfully securing and defending these vital economic benefits against regulatory scrutiny.

The information in this study is current as of the date of publication, and is provided for information purposes only. Although we do our absolute best in our attempts to avoid errors, we cannot guarantee that errors are not present in this study. Please contact a Swanson Reed member of staff, or seek independent legal advice to further understand how this information applies to your circumstances.